vs
Side-by-side financial comparison of GERON CORP (GERN) and PLAYSTUDIOS, Inc. (MYPS). Click either name above to swap in a different company.
PLAYSTUDIOS, Inc. is the larger business by last-quarter revenue ($55.4M vs $47.2M, roughly 1.2× GERON CORP). PLAYSTUDIOS, Inc. runs the higher net margin — -24.7% vs -39.0%, a 14.3% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs -18.3%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs -15.6%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.
GERN vs MYPS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $55.4M |
| Net Profit | $-18.4M | $-13.7M |
| Gross Margin | — | — |
| Operating Margin | -29.4% | -17.7% |
| Net Margin | -39.0% | -24.7% |
| Revenue YoY | 67.1% | -18.3% |
| Net Profit YoY | 30.3% | 38.9% |
| EPS (diluted) | $-0.03 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $55.4M | ||
| Q3 25 | $47.2M | $57.6M | ||
| Q2 25 | $49.0M | $59.3M | ||
| Q1 25 | $39.6M | $62.7M | ||
| Q4 24 | — | $67.8M | ||
| Q3 24 | $28.3M | $71.2M | ||
| Q2 24 | $882.0K | $72.6M | ||
| Q1 24 | $304.0K | $77.8M |
| Q4 25 | — | $-13.7M | ||
| Q3 25 | $-18.4M | $-9.1M | ||
| Q2 25 | $-16.4M | $-2.9M | ||
| Q1 25 | $-19.8M | $-2.9M | ||
| Q4 24 | — | $-22.4M | ||
| Q3 24 | $-26.4M | $-3.1M | ||
| Q2 24 | $-67.4M | $-2.6M | ||
| Q1 24 | $-55.4M | $-567.0K |
| Q4 25 | — | -17.7% | ||
| Q3 25 | -29.4% | -13.6% | ||
| Q2 25 | -25.4% | -5.9% | ||
| Q1 25 | -42.2% | -4.4% | ||
| Q4 24 | — | -33.1% | ||
| Q3 24 | -99.8% | -6.7% | ||
| Q2 24 | -7860.9% | -5.5% | ||
| Q1 24 | -18465.1% | -2.2% |
| Q4 25 | — | -24.7% | ||
| Q3 25 | -39.0% | -15.8% | ||
| Q2 25 | -33.4% | -5.0% | ||
| Q1 25 | -50.1% | -4.6% | ||
| Q4 24 | — | -33.1% | ||
| Q3 24 | -93.5% | -4.3% | ||
| Q2 24 | -7639.8% | -3.6% | ||
| Q1 24 | -18220.4% | -0.7% |
| Q4 25 | — | $-0.12 | ||
| Q3 25 | $-0.03 | $-0.07 | ||
| Q2 25 | $-0.02 | $-0.02 | ||
| Q1 25 | $-0.03 | $-0.02 | ||
| Q4 24 | — | $-0.18 | ||
| Q3 24 | $-0.04 | $-0.02 | ||
| Q2 24 | $-0.10 | $-0.02 | ||
| Q1 24 | $-0.09 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | $104.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $248.7M | $227.9M |
| Total Assets | $567.4M | $290.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $104.9M | ||
| Q3 25 | $78.1M | $106.3M | ||
| Q2 25 | $77.7M | $112.9M | ||
| Q1 25 | $83.7M | $107.1M | ||
| Q4 24 | — | $109.2M | ||
| Q3 24 | $60.3M | $105.2M | ||
| Q2 24 | $116.9M | $106.3M | ||
| Q1 24 | $189.8M | $127.0M |
| Q4 25 | — | $227.9M | ||
| Q3 25 | $248.7M | $238.9M | ||
| Q2 25 | $259.5M | $245.3M | ||
| Q1 25 | $268.2M | $244.1M | ||
| Q4 24 | — | $244.7M | ||
| Q3 24 | $292.3M | $265.2M | ||
| Q2 24 | $306.7M | $263.6M | ||
| Q1 24 | $344.9M | $288.4M |
| Q4 25 | — | $290.6M | ||
| Q3 25 | $567.4M | $299.2M | ||
| Q2 25 | $555.2M | $316.2M | ||
| Q1 25 | $562.5M | $313.8M | ||
| Q4 24 | — | $323.0M | ||
| Q3 24 | $444.9M | $330.6M | ||
| Q2 24 | $449.4M | $333.4M | ||
| Q1 24 | $482.1M | $357.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | $3.7M |
| Free Cash FlowOCF − Capex | — | $3.6M |
| FCF MarginFCF / Revenue | — | 6.5% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $25.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.7M | ||
| Q3 25 | $-13.6M | $5.7M | ||
| Q2 25 | $-27.4M | $13.6M | ||
| Q1 25 | $-48.0M | $3.3M | ||
| Q4 24 | — | $11.6M | ||
| Q3 24 | $-58.9M | $14.6M | ||
| Q2 24 | $-53.5M | $14.5M | ||
| Q1 24 | $-62.3M | $5.0M |
| Q4 25 | — | $3.6M | ||
| Q3 25 | — | $5.4M | ||
| Q2 25 | — | $13.2M | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | — | $13.9M | ||
| Q2 24 | $-53.7M | $12.8M | ||
| Q1 24 | $-62.9M | $3.6M |
| Q4 25 | — | 6.5% | ||
| Q3 25 | — | 9.3% | ||
| Q2 25 | — | 22.3% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | — | 19.6% | ||
| Q2 24 | -6086.6% | 17.6% | ||
| Q1 24 | -20680.3% | 4.6% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 0.0% | 0.9% | ||
| Q2 24 | 23.4% | 2.4% | ||
| Q1 24 | 202.3% | 1.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
